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Expression and Characterization of the CYP1 subfamily from Xenopus laevis 
Andy Schwartz ‘12 with mentor Wade Powell 
Kenyon College Summer Science 2011 
Members of the Cytochrome P4501 (CYP1) family of enzymes are critical in the metabolism of 
aromatic hydrocarbons and amines.  Their expression is typically induced by agonists of the aryl 
hydrocarbon receptor, which include many CYP1 substrates.  Multiple CYP1 paralogs have been 
characterized in diverse vertebrates, including fish, birds, and mammals.  While they share the ability 
metabolize many compounds, they are often distinguished by specific catalytic preferences, including 
natural products and fluorescent substrates.  For example mammalian CYP1A1 catalyzes 
oxygenation of aromatic hydrocarbons and the fluorescent substrate 7-ethoxyresorufin (7ER); 
CYP1A2 metabolizes caffeine and 7-methoxyresorufin (7MR).  CYP1A1, 1A2 and 1B1 all use 
estrogen and the endogenous AHR ligand FICZ as substrates.   
Our lab seeks to characterize the activities of inducible CYP1s from the frog, Xenopus laevis:  
CYP1A6, 1A7, 1B, and 1C.  While these CYPs have been sequenced and shown to be evolutionarily 
close, amino acid differencess in the putative active site suggest their catalytic activities may be 
different. I developed a system to overexpress the frog CYPs in E. coli using a genetically modified 
set of CYP1 plasmids.  An OmpA leader sequence replaced the native N-terminus to facilitate 
functional expression in the outer membrane.  I initially confirmed the utility of the engineered 
plasmids by expressing them in a cell free system and observing them on a Western Blot.  I then 
transformed the desired plasmids in Escherichia coli JM109 in an attempt to produce active proteins.  
Future studies will exploit these proteins to assess the catalytic differences between the frog CYP 
enzymes. 
Abstract 
1)  To culture JM109 E. Coli cells cotransformed with desired plasmids in order to overexpress 
CYP1A1, CYP1A2, CYP1A6, CYP1A7, CYP1B, and CYP1C in the bacterial cells and 
isolate active membrane proteins for future use in characterization 
2)  To normalize the necessary amount of each isolate by functional protein content. 
Objectives 
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•  We successfully used the genetically engineered CYP plasmids to express the full-length proteins 
in a cell-free environment (Western Blot, Figure 3). 
• Transformation of E. coli with the desired plasmids can produce active membrane proteins for 
further characterization (Western Blot, Figure 5). 
•   A CO difference spectrum will be used to assay the general activity of my CYP membrane 
proteins.  Absorption peaks at 450 nm will be indicative of useful proteins for activity 
characterization. 
•  After confirming pure samples of highly active CYP protein, I can begin to assess whether 
differences in the enzyme’s active sites are due to catalytic differences or redundancy in the 
genome of X. laevis. 
Conclusions & Future Work 
Vector Model of the Engineered Plasmid 
Figure 2. Vector model of the CYP plasmids engineered to be incorporated in the JM109 genome.  The 
addition of an N-terminus 21 amino acid residue leader sequence to the cDNA open reading frame for the 
desired CYP1 enables overexpression in E. coli.  In this way, the specific sequence encoding a CYP1 does not 
necessitate modification.  Furthermore, during growth, the modified leader sequence is removed leaving the 
unchanged and cotransformed CYP plasmid.  In addition, the added hexahistidine tag on the c-terminus does not 
change the sequence either, but does enable the visualization of an active protein on a Western Blot.  The 
CYP1A1 and CYP1A2 plasmids were provided by Fred Guengrich of Vanderbilt University, Nashville, TN.  The 
CYP1A6, CYP1A7, CYP1B, and CYP1C sequences were synthesized by Epoch Life Sciences, Sugar Land, TX. 
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Cell Free Expression of X. laevis CYP plasmids 
Figure 3. Western Blot of CYP cell-free kit expression products. Before engaging in 
the extensive process of membrane preparation, the functionality of our CYP plasmids 
were assessed by using E. coli lysates to synthesize the desired proteins.  Proteins were 
separated by 7% SDS-PAGE and detected on a Western Blot using an anitbody against 
the histidine tag (0.5 µg/mL, GenScript).   
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Figure 4. The process of 
membrane preparation. 
E. coli cells were 
transformed with CYP 
expression plasmids and 
were plated on LB agar 
over night.  Individual 
colonies were grown and 
treated to promote CYP 
overexpression.  Whole 
cells were broken down 
and seperated over a 
multistep process to 
produce active membrane 
proteins. Procedure was 
adapted from Pritchard et 
al. (2006). 
Co-transformed JM109 Competent E. coli  
cells with  
6 desired Cytochrome p450 plasmids (all 
engineered with ampicillin resistance), and the 
reductase plasmid (chloramphenicol resistant). 
Individual colonies from each plate were 
submerged in liquid LB containing ampicillin/
chloramphenicol 
A portion of the LB culture were submerged 
into modified TB with a phosphate buffer and 
both drugs and thiamine 
When the cells reached a level of growth 
deemed suitable by OD600, IPTG (lactose 
analog) and ALA (heme supplement) were 
added to the cultures, incubated for 22 hours, 
and centrifuged 
Cells were 
cultured on LB 
agar plates   
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Pellet: Whole cells were 
resuspended, treated with 
lysozyme for an hour, and 
then centrifuged 
Supernatant: 
Discarded 
Pellet: Spheroblasts were 
resuspended and treated with 
protease inhibtors. DNA was 
released from spheroblasts by 
sonication, and product was 
centrifuged 
Supernatant: 
Discarded 
Pellet: 
Discarded 
Supernatant: desired 
membranes were seperated 
by ultracentrifuge.  
Supernatant: 
Discarded 
Pellet: Membranes were 
resuspended and dispersed 
by a tissue homogenizer.  
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Results of Membrane Preparation 
250 
150 
100 
75 
50 
37 
25 
Cyp1A1 
6 µL 
250 
150 
100 
75 
50 
37 
25 
Cyp1A2 
6 µL 
250 
150 
100 
75 
50 
37 
25 
NC  Cyp1C  Cyp1B     Cyp1A7   Cyp1A6 
6 µL     8 µL    8 µL        8  µL        4 µL 
A. 
B. D. C. 
Figure 5. The results of the 
membrane preparation.  A. A 
standard curve of concentration 
versus absorbance at 595 nm to 
assess the protein content of each 
sample of prepared CYP proteins. I 
used this to adjust the loading 
volumes for Western Blotting.  
Western Blots depicting active 
protein: B. CYP1A1, C. CYP1A2, D. 
Frog CYPs.  Arrows depict desired 
protein presence.  Normalized 
loading volumes listed below each 
lane.  NC = negative control 
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• CYPs exist in many species and are 
characterized by the enzymes’ similar 
evolutionary tracks despite some radically 
different catalytic activities between 
organisms 
• Mammalian CYP1 (CYP1A1, CYP1A2, 
CYP1B1) expression is highly inducible by 
the AHR receptor, which activates 
transcription upon binding an exogenous 
ligand (i.e. TCDD); their activities are well-
documented. (highlighted in blue on figure 1) 
• Alternatively, X. laevis CYP1 (CYP1A6, 
CYP1A7, CYP1B, CYP1C) are less 
responsive to an AHR ligand.  Nothing is 
known about the catalytic activity of the frog 
CYP1s. (highlighted in red on figure 1) 
• The characterization of any differences 
between  CYP1A6 and CYP1A7 will answer 
significant questions regarding the functional 
redundancy and the nature of the 
evolutionary divergence of these two 
cytochromes 
• Isolated CYP1 plasmids can be 
cotransformed and overexpressed in 
modified strains of E. coli to produce 
functional membrane proteins for 
characterization and assay in a timely 
fashion. 
• An OmpA leader sequence and hexa-
histidine tail tag enable the efficient 
membrane insertion and detection of the 
desired plasmids in E. coli. 
Background 
Figure 1. A phylogenetic tree depicted the  
evolution of CYPs from various organisms. 
Amino acid sequences were aligned and 
organized by ClustalX. 
CYPs 
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